Article
A site-directed mutant of Cu,Zn-superoxide dismutase modeled after native extracellular superoxide dismutase.
Biological trace element research - 1 Jan 1995
Gao B, Flores S C, McCord J M
Abstract excerpt
The well-studied cytosolic Cu,Zn-superoxide dismutase (SOD) protects against reperfusion injury, although its short (6 min) plasma half-life and negative charge create undesirable pharmacokinetics. We have designed, cloned, and expressed a genetic variant of SOD with altered pharmacological properties. A fusion gene consisting of the entire coding region of human SOD followed by a positively charged...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
